Cargando…

Current Surgical Indications for Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: The management strategy for the treatment of non-small-cell lung cancer (NSCLC) has been transformed by our improved understanding of the cancer biology and concomitant development of novel systemic therapies. Complete surgical resection of NSCLC continues to offer the best chance fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deboever, Nathaniel, Mitchell, Kyle G., Feldman, Hope A., Cascone, Tina, Sepesi, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909782/ https://www.ncbi.nlm.nih.gov/pubmed/35267572 http://dx.doi.org/10.3390/cancers14051263

Ejemplares similares

Emerging Therapies in Thoracic Malignancies—Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non–Small Cell Lung Cancer
por: Sepesi, Boris, et al.
Publicado: (2020)

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer
por: Pradhan, Monika, et al.
Publicado: (2021)

Intraoperative challenges after induction therapy for non–small cell lung cancer: Effect of nodal disease on technical complexity
por: Feldman, Hope A., et al.
Publicado: (2022)

Circulomic variables predict pathologic staging preoperatively in treatment-naïve non-small cell lung cancer
por: Deboever, Nathaniel, et al.
Publicado: (2023)

Outcomes after thymectomy in non-thymomatous myasthenia gravis
por: Deboever, Nathaniel, et al.
Publicado: (2023)

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy
por: Pataer, Apar, et al.
Publicado: (2022)

Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?
por: Deboever, Nathaniel, et al.
Publicado: (2022)

Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort
por: Mitchell, Kyle G, et al.
Publicado: (2020)

Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature
por: Bloom, Brooke C., et al.
Publicado: (2017)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer
por: Cascone, Tina, et al.
Publicado: (2021)

Patient selection for minimally-invasive resection of complex, central lung tumors: taking account of the surgeon’s eyeball test
por: Deboever, Nathaniel, et al.
Publicado: (2023)

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
por: Parra, Edwin R., et al.
Publicado: (2018)

Lung Metastases: Current Surgical Indications and New Perspectives
por: Mangiameli, Giuseppe, et al.
Publicado: (2022)

Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes
por: Shah, Parin, et al.
Publicado: (2022)

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer
por: Tang, Chad, et al.
Publicado: (2018)

Mediastinal esophageal leiomyosarcoma abutting a retroesophageal right subclavian artery: A case report
por: Corsini, Erin M., et al.
Publicado: (2019)

Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
por: Duchemann, Boris, et al.
Publicado: (2021)

Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022)

Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
por: Hong, Lingzhi, et al.
Publicado: (2023)

Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers
por: Vicidomini, Giovanni, et al.
Publicado: (2020)

A case report of a midesophageal diverticulum mimicking a fibrovascular esophageal polyp
por: Mitchell, Kyle G., et al.
Publicado: (2019)

Comprehensive T cell repertoire characterization of non-small cell lung cancer
por: Reuben, Alexandre, et al.
Publicado: (2020)

Salivary cytokine panel indicative of non-small cell lung cancer
por: Koizumi, Tomonobu, et al.
Publicado: (2018)

Iterative surgical resections in non-small cell lung cancer
por: Ucvet, Ahmet, et al.
Publicado: (2022)

Oligometastatic non-small cell lung cancer: Current management
por: Román-Jobacho, Alicia, et al.
Publicado: (2021)

Current status of immunotherapy for non-small cell lung cancer
por: Yang, Tao, et al.
Publicado: (2022)

Commentary: Expanding the Surgical Indications in Lung Cancer
por: Park, Seong Yong
Publicado: (2023)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
por: Brahmer, Julie R., et al.
Publicado: (2018)

Targeted therapies in non-small cell lung cancer
por: Kyle, Fiona, et al.
Publicado: (2008)

Commentary: Boot camps may improve skills, but how can they be further strengthened?
por: Deboever, Nathaniel, et al.
Publicado: (2022)

Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer – significance and development
por: Cascone, Roberto, et al.
Publicado: (2017)

Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013)

Surgical treatment in non-small cell lung cancer with pulmonary oligometastasis
por: He, Jinyuan, et al.
Publicado: (2017)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

EGFR and non-small cell lung cancer: implications for surgical practice
por: Varela, Gonzalo, et al.
Publicado: (2020)

Role of Surgical Intervention in Unresectable Non-Small Cell Lung Cancer
por: Suzuki, Shigeki, et al.
Publicado: (2020)

Oligometastatic non-small-cell lung cancer: current treatment strategies
por: Richard, Patrick J, et al.
Publicado: (2016)

Current management of RET rearranged non-small cell lung cancer
por: Stinchcombe, Thomas E
Publicado: (2020)

Current treatment landscape for oligometastatic non-small cell lung cancer
por: Garde-Noguera, Javier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pvj3rittr3bk3v1ql6ats3jc42